Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quality of life after myomectomy according to the surgical approach and MED12 mutation status.

European journal of obstetrics, gynecology, and reproductive biology - 1 Oct 2024

Äyräväinen Anna, Vahteristo Maija, Khamaiseh Sara, Heikkinen Tuomas, Ahvenainen Terhi, Härkki Päivi, Vahteristo Pia

Abstract excerpt

OBJECTIVE: Molecular status of uterine leiomyomas has been shown to affect both tumor characteristics and treatment response. Mutations in mediator complex subunit 12 (MED12), the most prevalent alterations in leiomyomas, are associated with tumor size and number of leiomyomas. Myomectomy can be performed by laparoscopy or by open abdominal surgery, depending on the size and number of leiomyomas removed. The aim...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Laparoscopy
Share to Leiomyoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mediator Complex

Share to Mutation

Share to Quality of Life

Share to Uterine Neoplasms

Source

Identifiers

PMID: 39137592
DOI: 10.1016/j.ejogrb.2024.08.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quality of life after myomectomy according to the surgical approach and MED12 mutation status.PMID 39137592Read ↗

Frequency of MED12 Mutation in Relation to Tumor and Patient's Clinical Characteristics: a Meta-analysis.Semantic proximity Read ↗

Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.Semantic proximity Read ↗

The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.Semantic proximity Read ↗

Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyomaSemantic proximity Read ↗

MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.Semantic proximity Read ↗

Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.Semantic proximity Read ↗

Med12 gain-of-function mutation causes leiomyomas and genomic instabilitySemantic proximity Read ↗

Clinical and Pathological Profiles and Recurrence Risk Factors of Uterine Leiomyoma Variants：A Retrospective Cohort StudySemantic proximity Read ↗

Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.Semantic proximity Read ↗

MED12 mutation frequency in unselected sporadic uterine leiomyomas.Semantic proximity Read ↗

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.Semantic proximity Read ↗

Clinical and molecular risk factors for repeat interventions due to symptomatic uterine leiomyomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.